>> Download Survival Reports <<

>> Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial << (from: investor.lilly.com)

Published 2 weeks ago